Feasibility of telemonitoring in hematology patients: a narrative review
Open Access
- 24 March 2025
- journal article
- Published by Pirogov National Medical and Surgical Center in Medical doctor and information technologies
- No. 1,p. 22-29
Abstract
Literature data presented in open medical sources on the use of telemedicine in hematology were analyzed. Telemedicine is an effective way to manage and monitor patients in order to minimize in-person hospital visits when this can be avoided. The experience and perspectives of this type of interaction in terms of patient satisfaction and effectiveness in monitoring various hematologic diseases have been studied. Despite the small number of results with high evidence, the studies demonstrate an optimistic picture of the use of telemedicine in real clinical practice, which leads to the need for more large-scale and high-quality studies to introduce various forms of telemonitoring in the routine follow-up of hematologic patients.Keywords
This publication has 17 references indexed in Scilit:
- COVID19 in hematological patients and telemedicine: lessons learned across Europe and the USCurrent Opinion in Infectious Diseases, 2022
- Feasibility of Wearable-Based Remote Monitoring in Patients During Intensive Treatment for Aggressive Hematologic MalignanciesJCO Clinical Cancer Informatics, 2022
- Pilot Implementation of Remote Patient Monitoring Program for Outpatient Management of CAR-T Cell TherapyBlood, 2021
- Home Spirometry Telemonitoring for Early Detection of Bronchiolitis Obliterans Syndrome in Patients with Chronic Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2021
- Analysis of the Implementation of Telehealth Visits for Care of Patients With Cancer in Houston During the COVID-19 PandemicJCO Oncology Practice, 2021
- Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID‐19) pandemic: selection criteria and patients’ satisfactionBritish Journal of Haematology, 2020
- Tele-Medicine Services in Hematological Practice During Covid Pandemic: Its Feasibility and DifficultiesIndian Journal of Hematology and Blood Transfusion, 2020
- Following-up allogeneic transplantation recipients during the COVID-19 pandemicThe Lancet Haematology, 2020
- Feasibility and Acceptability of Using a Telehealth Platform to Monitor Cardiovascular Risk Factors in Hematopoietic Cell Transplantation Survivors at Risk for Cardiovascular DiseaseTransplantation and Cellular Therapy, 2020
- Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2020